Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Afatinib Her2'

Afatinib Her2 published presentations and documents on DocSlides.

William J.

William J.

  • tawny-fly
  • 6 Slides

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

Thierry

Thierry

  • cheryl-pisano
  • 40 Slides

Le Chevalier, . MD. The Role of Translational Res...

James Yang,

James Yang,

  • pasty-toler
  • 93 Slides

MD. The Evolving Treatment Landscape in NSCLC: Co...

iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung

iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung

  • berey
  • 45 Slides

Interview with Shirish M . Gadgeel. , MD . January...

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

  • test
  • 25 Slides

First . Line and Beyond. Moderator:. Joseph Gligo...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 32 Slides

Clinical Practice Guideline Update. American Soci...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

  • danika-pritchard
  • 0 Slides

Clinical Practice Guideline Update. American Soci...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

  • danika-pritchard
  • 0 Slides

ASCO-CAP Recommendations For HER2 Testing in Brea...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

  • marina-yarberry
  • 68 Slides

Management of HER2 Over-Expressed Breast Cancer i...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

  • norah
  • 38 Slides

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

  • carny
  • 14 Slides

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

  • arya
  • 28 Slides

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

  • ximena
  • 32 Slides

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

  • alida-meadow
  • 59 Slides

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

  • luanne-stotts
  • 0 Slides

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

  • debby-jeon
  • 0 Slides

Monica Brown, MPH, PhD. . California Cancer Regi...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

  • liane-varnes
  • 0 Slides

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

  • alexa-scheidler
  • 0 Slides

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

  • spottletoefacebook
  • 66 Slides

Grazia Arpino. Università di Napoli Federico II. ...

Product Pipeline Neratinib

Product Pipeline Neratinib

  • coursion
  • 1 Slides

across the breast cancer therapy spectrum. Phase I...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

  • katrgolden
  • 50 Slides

Contents PageIntended Use 4Summary and Explanation...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

  • Kingslayer
  • 19 Slides

A. University of Tennessee Medical Center – Knox...

Nanotek & Expo 2014

Nanotek & Expo 2014

  • DaintyLittlePrincess
  • 16 Slides

Biodegradable . nanobrushes. for drug delivery. ...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

  • emery
  • 8 Slides

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

Central Asian Journal of

Central Asian Journal of

  • cady
  • 10 Slides

15 Medical and Pharmaceutical Sciences Innovation ...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

  • elizabeth
  • 49 Slides

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

  • wang
  • 55 Slides

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

  • gelbero
  • 35 Slides

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

  • lily
  • 29 Slides

Senior Investigator, . Breast Cancer Research. Ten...

CA BREAST D r S ana

CA BREAST D r S ana

  • oconnor
  • 68 Slides

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

  • unita
  • 31 Slides

Dr. Vicente Marco. Department of Pathology. Hospit...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

  • caroline
  • 43 Slides

Lisa A. Carey MD, . ScM. University of North Carol...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

  • unita
  • 59 Slides

Percent with Patients. Number of Patients (Median)...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

  • delcy
  • 117 Slides

Trastuzumab-emtansine. : A . very. . nice. . poi...

Metastatic triple-positive

Metastatic triple-positive

  • marcos147
  • 59 Slides

breast. . cancer. . needs. . different. . ther...

Cost of & Access to

Cost of & Access to

  • kittie-lecroy
  • 16 Slides

Molecularly Targeted Therapies as Barriers to Opt...

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

  • alida-meadow
  • 42 Slides

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

Translating NGS Data into a Clinically Actionable Assay

Translating NGS Data into a Clinically Actionable Assay

  • danika-pritchard
  • 41 Slides

Elaine R. Mardis, Ph.D.. Professor of Genetics. C...

Evaluation of HR[ER/

Evaluation of HR[ER/

  • debby-jeon
  • 60 Slides

PgR. ] status and correlation with Ki67 expres...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

  • lois-ondreau
  • 31 Slides

Lauren Barney. April 17, 2013. Breast Cancer Subt...

Copyright © 2024 DocSlides. All Rights Reserved